Curai Health, an AI-powered virtual primary care platform, raised $27.5 million in a Series B funding round.
Morningside Ventures led the round, with participation from General Catalyst and Khosla Ventures. Including the latest funding round, Curai Health has raised $57 million to date.
Curai Health provides chat-based primary care services.
Previously available only direct-to-consumer, Curai Health also announced that it will now support enterprise partnerships, including payers, employers, and public-sector organizations. Curai Health aims to partner with enterprises that want an affordable primary care option for everyone in their organization, especially those with people who sometimes struggle with the cost of care, like hourly employees, gig workers, and those with high-deductible health plans.
To date, more than 350,000 patient visits have occurred on the Curai Health platform, with its AI achieving nearly a 90% diagnosis accuracy rate.
“Primary care should be just that – primary – to every single person, but without drastic innovation, the current system will only create more scarcity, higher costs and a sicker population,” said Neal Khosla, co-founder and CEO of Curai Health.
“AI has the power to scale the care provided by a finite number of physicians so that it can meet the demands of a global population. We’ve dedicated countless hours to in-depth clinical and technical R&D to ensure our system gets smarter, more efficient, and increasingly cost-effective after every patient encounter. We aren’t interested in the 10- to 20-percent cost savings that most virtual care platforms aspire to deliver. We’re working toward 10 and, eventually 100x, care-delivery cost reductions.”
Curai Health is accessible to patients 24/7, supporting them with as many questions and follow-ups as needed. Patient care teams are led by U.S. licensed physicians and medically trained Clinical Associates, who are both supported by the AI. The AI works as part of the care team, sitting alongside providers, making suggestions, and automating more low-value tasks. It also will listen and learn from each patient encounter, ensuring it gains a greater understanding of medical language, symptomatology, and condition diagnosis – while also delivering increasingly high-quality patient care.
Currently available in California, Curai Health will use the funding to continue innovating its technology and expand its services and footprint more broadly. As part of the funding deal, Stephen Bruso from Morningside Ventures will join its board.
Image Credit: Curai Health